HOME > News Releases

News Releases

2015.02.26
R&D
PDF/326KB
Sunovion Pharmaceuticals Inc. Announces Initiation of Phase 3 Clinical Trial Program for SUN-101/eFlow® (Glycopyrrolate) in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)
2015.01.29
Finances
PDF/308KB
Supplementary Financial Data for the Third Quarter of the Year Ending March 31, 2015
2015.01.29
Finances
PDF/155KB
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2015 [Japanese GAAP] (Unaudited)
2015.01.29
Licensing
PDF/108KB
Sumitomo Dainippon Pharma Announces Collaboration on Lurasidone, an Atypical Antipsychotic Agent, for Thailand, Singapore and Hong Kong
2015.01.14
Corporate
PDF/165KB
Sunovion Pharmaceuticals Inc. Files Patent Infringement Lawsuits Regarding Latuda
2015.01.07
R&D
PDF/196KB
Sunovion Pharmaceuticals Inc. Announces FDA Acceptance for Review of Supplemental New Drug Application for the Use of Aptiom (eslicarbazepine acetate) as Monotherapy Treatment for Partial Onset Seizures
More News Releases

Page Top